期刊文献+

抗CD11c磁珠阳性选择法分离肺癌组织浸润树突状细胞

Positive selection using anti-CD11c magnetic beads for isolation of tumor infiltrating dendritic cells in lung cancer tissues
下载PDF
导出
摘要 目的:建立抗CDI1c磁珠阳性选择法分离Lewis肺癌模型中肿瘤浸润树突状细胞(tumor infiltrating dendritic cell,TIDC)的方法。方法:在C57BL/6小鼠侧腹壁皮下注射Lewis肺癌细胞(1.0×10^6/只)建立荷瘤小鼠模型。抗CD11c磁珠阳性选择法分离提取TIDC,抗小鼠CD11c-PE标记TIDC,用流式细胞仪检测分离到的细胞纯度;电镜观察细胞形态;抗小鼠MHC-Ⅱ-PE和CD83-FITC或CD86-FITC抗体双标记后,用流式细胞术检测细胞表型。结果:抗CD11c磁珠阳性选择法可在每克Lewis肺癌移植瘤组织中分离到(1.73±0.31)×10^6个TIDC,占肿瘤组织细胞总数的(2.18±0.29)%;TIDC纯度达到96.49%。电镜观察到分离的TIDC具有DC细胞的典型形态特征,其细胞表面MHC-Ⅱ、CD83和CD86分子的表达率分别为(51.25±4.21)%、(3.48±0.34)%和(3.07±0.65)%。结论:抗CD11c磁珠阳性选择法体外分离TIDC具有高效、简便、相对经济实用的优点,有推广价值。 Objective:To establish a method for isolating tumor infiltrating dendritic cells (TIDC) from mice models of Lewis lung cancer by positive selection using anti-CD11 c magnetic beads. Methods: A total of 1.0 × 10^6 Lewis lung cancer cells were subcutaneously injected into a C57BL/6 mice at the lateral abdominal wall to establish the mouse model of lung cancer. TIDC were isolated positively using anti-mouse CD11 c magnetic beads; they were labeled by anti -mouse CD11 c, and then the purity of the isolated cells was tested by FACScan flow cytometer. The cells were also double labeled by PE-conjugated MHC- Ⅱ/ mAb and FITC-conjugated CD83 mAb or FITC-conjugated CD86 mAb to analyze the phenotype of cells by FACScan flow cytometer. Results: The positive selection using anti-CD11c magnetic beads isolated (1.73± 0. 31 ) ×10^6 TIDC from each gram of Lewis lung cancer tissue, which accounted for (2.18 ±0.29)% of the cells in the tumor tissues. The purity of TIDC was 96.49%. Electron microscope showed that the isolated TIDC had the typical character of DC cells. The positive rates of MHC-Ⅱ , CD83 and CD86 molecules in TIDC surface were (51.25 ±4.21 )%, (3.48 ± 0.34) % and ( 3.07 ± 0.65 ) %, respectively. Conclusion : The positive selection using anti-CD11 c magnetic beads is highly effective, simple, and economic, and is worth popularizing.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2008年第6期581-584,共4页 Chinese Journal of Cancer Biotherapy
基金 复旦大学附属华山医院科研基金(No.145)~~
关键词 肿瘤浸润树突状细胞 CD11c磁珠阳性选择法 肺癌细胞 细胞分离 tumor infiltrating dendritic cells anti-CD11 c magnetic beads lung neoplasms cell cell separation
  • 相关文献

参考文献18

  • 1Reschner A, Hubert P, Delvenne P, et al. Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response[J]. Clin Exp Immunol, 2008, 152(2): 219- 226.
  • 2Ferrantini M, Capone I, Belardelli F. Dendritic cells and cytokines in immune rejection of cancer[ J ]. Cytokine Growth Factor Rev, 2008, 19(1): 93-107.
  • 3Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor[ J]. J Exp Med, 1992,176(6) :1693-1702.
  • 4Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow[ J]. J Immunol Methods. 1999 , 223 (1): 77-92.
  • 5Nencioni A, Grunebach F, Schmidt SM, et al. The use of dendritic cells in cancer immunotherapy[ J]. Crit Rev Oncol Hematol, 2008, 65(3) : 191-199.
  • 6Ballestrero A, Boy D, Moran E, et al. Immunotherapy with dendritic cells for cancer[ J ]. Adv Drug Deliv Rev, 2008, 60 (2) :173-183.
  • 7Nagorsen D, Voigt S, Berg E, et al. Tumor-infihrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival[ J]. J Transl Med, 2007, 5: 62.
  • 8Chiodoni C, Paglia P, Stoppacciaro A, et al. Dendritic cells infiltrating tumors eotransduced with graaulocyte/macrophage colonystimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response [ J]. J Exp Med. 1999,190( 1 ) :125-133.
  • 9Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells [J].Annu Rev Immunol. 2000 ;18:767-811.
  • 10Preynat-Seauve O, Schuler P, Contassot E, et al. Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection [ J]. J Immunol, 2006, 176(1) : 61-67.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部